Henri Roukoz, MD

Associate Professor of Medicine, Cardiovascular Division

Henri Roukoz

Contact Info

Mailing Address:
420 Delaware Street SE
MMC 508 Mayo
8508A (Campus Delivery Code)
Minneapolis, MN 55455

Administrative Assistant Name
Wendy Markuson

Administrative Email

Additional Locations

M Health Fairview Clinics & Surgery Center

Associate Professor of Medicine, Cardiovascular Division

Director of Complex and Congenital Ablation

Cardiologist - Electrophysiology

Medical School, Saint Joseph's University, Beirut, Lebanon

Residency, Cleveland Clinic, Cleveland, OH

Fellowship, University of Minnesota, Minneapolis, MN

Master's Degree, Biological and Medical Sciences, Beirut, Lebanon



  • Ventricular tachycardia ablation
  • Atrial fibrillation ablation
  • Congenital heart disease arrhythmia
  • Advanced device therapy

Awards & Recognition

  • 2018 TOP Doctors: Rising Star, April 2018
  • 2017 TOP Doctors: Rising Star, April 2017
  • 2016 TOP Doctors: Rising Star, April 2016
  • Clinical Excellence Award, University of Minnesota, Department of Medicine, 2014
  • Cleveland Clinic Clinical Scholar Program Award, 2006



  1. Sholevar DP, Tung S, Kuriachan V, Leong-Sit P, Roukoz H, Engel G, Kutalek SP, Akula D, Thompson AE, Christie MGT, Ostanniy M, Molin F; SPACE study investigators.Feasibility of Extravascular Pacing with a Novel Substernal Electrode Configuration: The Substernal Pacing Acute Clinical Evaluation (SPACE) Study: The Substernal Pacing Acute Clinical Evaluation Study. Heart Rhythm. 2017 Nov 29.[Epub ahead of print] [PMID: 29197657]
  2. Roukoz H, Benditt DG. Atrial arrhythmias after lung transplantation. Trends Cardiovasc Med. 2017 Aug 1. pii: S1050-1738. [PMID 28797718]
  3. Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, Okumura K, Serota H, Nordaby M, Guiver K, Biss B, Brouwer MA, Grimaldi M; RE-CIRCUIT InvestigatorsUninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation. N Engl J Med. 2017 Apr 27;376(17):1627-1636. [PMID: 28317415]
  4. Chang IC, Agamawi YM, Austin E, Adkisson WO, Roukoz H, von Wald LN, Sakaguchi S, Benditt DG, Chen LY. Usefulness of Atrial Fibrillation as a Marker for Adverse Cardiovascular Outcomes in Both Primary and Secondary Prevention in Patients with Implantable Cardioverter-Defibrillators. American Journal of Cardiology. 2016;118(10): 1497-1502. [PMID 27649879]
  5. Vakil K, Kazmirczak F, Sathnur N, Adabag S, Cantillon DJ, Kiehl EL, Koene R, Cogswell R, Anand I, Roukoz H. Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology Heart Failure. 2016;4(10):772-9. [PMID 27395347]
  6. Vakil KP, Roukoz H, Tung R, Levy WC, Anand IS, Shivkumar K, Rector TS, Vaseghi M, Tholakanahalli V. Mortality Prediction using a modified Seattle Heart Failure Model may improve patient selection for ventricular tachycardia ablation. American Heart Journal. 2015;170(6):1099-104. [PMID 2667831]
  7. Roukoz H, Shah M, Masilamani LJ, Thachil A, Jayakumar PK, Benditt DG, Narasimhan C. fQRS as a marker of granulomatous disease in patients presenting with ventricular tachycardia and normal left ventricular ejection fraction. Indian Heart Journal. 2015;67(3):222-6. [PMID 26138178]
  8. Vakil K,Roukoz H, Sarraf M, Krishnan B, Reisman M, Levy WC, Adabag S. Safety and efficacy of the MitraClip® system for severe mitral regurgitation: A Systematic ReviewCatheter Cardiovasc Interv. 2014;84(1):129-36. [PMID 24323764] IF 2.396 (Study design and analysis, editing and review)
  9. Akkaya M, Roukoz H, Adabag S, Benditt DG, Anand I, Li JM, Zakharova M, Tholakanahalli V. Improvement of left ventricular diastolic function and left atrial reverse remodeling after catheter ablation of premature ventricular complexes. Journal of Interventional Cardiac Electrophysiology.2013;38(3):179-85. [PMID 24132717] IF 1.552 (Study design, editing and review)
  10. Akkaya M, Roukoz H, Adaba? S, Peter A, Li JM, Tholakanahalli V. Efficacy and benefits of catheter ablation of ventricular premature complexes in patients younger and older than 65 years of age. Turk Kardiyol Dern Ars. 2013;41(6):497-504. [PMID 24104974] IF 1.996 (Study design, editing and review.)



University of Minnesota Medical Center

Board Certifications

  • Clinical Cardiac Electrophysiology Boards 2013-2023
  • Cardiovascular Medicine Boards 2011-2021 
  • National Board of Echocardiography Examination 2010-2020 
  • ABIM Board Certification: Internal Medicine 2008-2018

Clinical Interests

Advanced device therapy, Atrial fibrillation ablation, Cardiac sarcoidosis, Congenital heart disease arrhythmia, Ventricular tachycardia ablation

Hospital Privileges

M Health Fairview University of Minnesota Medical Center